Connect Biopharma Holdings Ratios (2022-2026) | CNTB

Ratios Dec2022 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -1,051.60%-1,260.74%-26,758.33%-107,118.75%-11,449.70%
EBIT Margin (Quarter) -1,135.85%-1,378.08%-27,966.67%-110,481.25%-11,601.78%
EBITDA Margin (Quarter) -1,009.52%-1,431.23%-26,393.75%-106,887.50%-11,402.37%
Operating Margin (Quarter) -1,135.85%-1,378.08%-27,966.67%-110,481.25%-11,601.78%
Net Margin (Quarter) -1,056.28%-1,275.93%-26,872.92%-107,500.00%-11,478.11%
FCF Margin (Quarter) -1,079.08%-377.08%-26,862.50%-109,000.00%-9,470.41%
Efficiency
Assets Average (Quarter) 159.05M135.73M96.98M87.70M75.04M61.72M58.07M
Equity Average (Quarter) 143.54M115.08M97.70M102.41M105.79M96.41M87.53M77.12M63.36M48.68M42.30M
Invested Capital (Quarter) 158.42M128.66M101.50M93.89M110.93M100.65M92.17M82.90M71.34M55.37M41.98M42.62M
Asset Utilization Ratio (Quarter) 0.020.010.000.00
Leverage & Solvency
Equity Ratio (Quarter) 0.910.890.800.920.910.890.860.820.750.71
Valuation
Enterprise Value (Quarter) -235.26M-81.61M-118.30M-110.17M-18.50M-84.01M-71.73M-54.78M-44.34M-15.90M
Return Ratios
Return on Sales (Quarter) -0.11%-0.13%-2.69%-10.75%-8.67%-1.15%
Return on Capital Employed (Quarter) -24.05%-62.80%-82.00%-120.72%-161.45%
Return on Invested Capital (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.02%
Return on Assets (Quarter) 0.00%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.02%